Enforced HCELL expression: empowering "Step 1" to optimize the efficacy of mesenchymal stem/stromal cell therapy for stroke and other clinical conditions Other Scholarly Work

cited authors

  • Sackstein, Robert

sustainable development goals

authors

publication date

  • November 8, 2024

published in

keywords

  • Biotechnology & Applied Microbiology
  • CD44
  • CNS conditions
  • Cell & Tissue Engineering
  • Cell Biology
  • E-selectin
  • FUCOSYLATION
  • GPS
  • HCELL
  • Hematology
  • Life Sciences & Biomedicine
  • MSC
  • Oncology
  • Science & Technology
  • cell therapy
  • cytotherapeutics
  • exofucosylation
  • fucosyltransferase
  • glycan editing
  • glycobiology
  • glycocalyx editing
  • glycoengineering
  • glycosyltransferase-programmed stereosubstitution
  • ischemia-reperfusion injury
  • regenerative medicine
  • selectin
  • stroke
  • translational glycobiology

WoS ID

  • 001351012500001

Digital Object Identifier (DOI)

start page

  • 1027

end page

  • 1030

volume

  • 42

issue

  • 12

open access

  • true